MoneyWorks4Me

Orchid Pharma - Quaterly Results

12 Aug 2025 Evaluate
The sales is pegged at Rs. 1729.29 millions for the June 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 2444.06 millions during the year-ago period.Profit after Tax for the quarter ended June 2025 saw a decline of -37.48% from Rs. 291.03 millions to Rs. 181.96  millions.Operating profit for the quarter ended June 2025 decreased to 301.08 millions as compared to 410.20 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1729.29 2444.06 -29.25 1729.29 2444.06 -29.25 9219.26 8193.68 12.52
Other Income 159.30 77.72 104.97 159.30 77.72 104.97 319.29 303.89 5.07
PBIDT 301.08 410.20 -26.60 301.08 410.20 -26.60 1554.60 1410.70 10.20
Interest 32.58 34.73 -6.19 32.58 34.73 -6.19 145.40 163.28 -10.95
PBDT 268.50 375.47 -28.49 268.50 375.47 -28.49 1409.20 1247.42 12.97
Depreciation 86.54 84.44 2.49 86.54 84.44 2.49 344.36 332.19 3.66
PBT 181.96 291.03 -37.48 181.96 291.03 -37.48 1064.84 915.23 16.35
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -32.26 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -32.26 0.00
PAT 181.96 291.03 -37.48 181.96 291.03 -37.48 1064.84 947.49 12.39
Equity 507.19 507.19 0.00 507.19 507.19 0.00 507.19 507.19 0.00
PBIDTM(%) 17.41 16.78 3.74 17.41 16.78 3.74 16.86 17.22 -2.06
Peers
Company Name CMP
Sun Pharma. Inds. 1850.90
Dr. Reddys Labs. 1143.15
Cipla 1361.00
Lupin 2048.30
Zydus Lifesciences 1097.90
View more..